T1FX34 Stock Overview Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Teleflex Incorporated Competitors Price History & Performance
Summary of share price highs, lows and changes for Teleflex Historical stock prices Current Share Price US$109.30 52 Week High US$122.56 52 Week Low US$99.77 Beta 1.16 1 Month Change 0% 3 Month Change n/a 1 Year Change n/a 3 Year Change -45.35% 5 Year Change n/a Change since IPO -31.47%
Recent News & Updates
Teleflex Incorporated Revises Earnings Guidance for the Year 2024 Nov 02
Teleflex Incorporated Announces Quarterly Dividend, Payable December 16, 2024 Oct 31
Teleflex Incorporated Announces First Patient Enrolled Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy Oct 29
Teleflex Incorporated Launches Next-Generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada Oct 25
Teleflex Incorporated Announces the Presentation of Data Supporting the Safety and Efficacy of Barrigel Rectal Spacer Oct 17 Teleflex Incorporated Revises Earnings Guidance for the Full Year 2024 See more updates
Teleflex Incorporated Revises Earnings Guidance for the Year 2024 Nov 02
Teleflex Incorporated Announces Quarterly Dividend, Payable December 16, 2024 Oct 31
Teleflex Incorporated Announces First Patient Enrolled Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy Oct 29
Teleflex Incorporated Launches Next-Generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada Oct 25
Teleflex Incorporated Announces the Presentation of Data Supporting the Safety and Efficacy of Barrigel Rectal Spacer Oct 17 Teleflex Incorporated Revises Earnings Guidance for the Full Year 2024
Teleflex Incorporated Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray May 10
Teleflex Incorporated Announces Quarterly Cash Dividend, Payable on June 14, 2024 May 08 Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024 Teleflex Incorporated, Annual General Meeting, May 03, 2024 Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024
Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement Jan 09
Teleflex Incorporated Announces First Patient Enrollment in ACCESS-MANTA Registry Nov 18
Teleflex Incorporated Announces A New Peer-Reviewed Study in the Nature Journal Prostate Cancer and Prostatic Diseases Confirms the Position of the UroLift System as the Gold Standard in Minimally Invasive Surgical Treatment Nov 15 Teleflex Incorporated Provides Earnings Guidance for the Full Year 2023
Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million. Oct 12
Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million. Oct 11
Teleflex Incorporated Announces Extension of Arrow ErgoPack Complete System to Hemodialysis and Large Bore Central Venous Catheters Aug 22 Teleflex Incorporated Updates Earnings Guidance for the Year 2023
Teleflex Incorporated Receives FDA Clearance for Expanded Indication for QuikClot Control+(TM) Hemostatic Device Usage in Cardiac Surgical Procedures Aug 02
Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB for $650 million. Jul 28
Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB from Östersjöstiftelsen, Endowment Arm, Praktikerinvest AB and Recipharm Venture Fund AB for $650 million. Jul 27
Teleflex Incorporated Receives FDA Clearance for the Wattson Temporary Pacing Guidewire Jun 08
Teleflex Incorporated Announces the Arrow(R) EZ-Io(R) Needle Is Now FDA Cleared for Use in an MRI Environment Jun 07
Teleflex Announces Quarterly Dividend, June 15, 2023 May 09
Teleflex Incorporated Provides Earnings Guidance for the Year 2023 May 05
Teleflex Incorporated Announces Worldwide Recall of Affected Lots of Gibeck Iso-Gard Filter Products Nov 04 Teleflex Incorporated Revises Earnings Guidance for the Year 2022
Teleflex Incorporated (NYSE:TFX) completed the acquisition of Standard Bariatrics, Inc. Sep 29
Teleflex Incorporated Launches New Arrow® Pressure Injectable Midline Catheter Portfolio Sep 28
Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Standard Bariatrics, Inc. for $300 million. Aug 23 Teleflex Incorporated Provides Earnings Guidance for the Full Year of 2022
Teleflex Incorporated (NYSE:TFX) acquired unknown stake in Traverse Vascular Inc. Jul 01
Teleflex Incorporated Announces First Patient Enrollment in MANTA Ultra Study Jun 23
Teleflex Launches New Arrow Pressure Injectable Midline Catheter in Australia and New Zealand Jun 14
Teleflex Incorporated Launches New Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa Region Jun 07
Teleflex Incorporated Reaffirms Earnings Guidance for the Full Year of 2022 May 21
Teleflex Incorporated Announces Regulatory Clearance for Its Urolift® System in China for the Treatment of Benign Prostatic Hyperplasia May 20
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device May 19
Teleflex Incorporated Declares Quarterly Cash Dividend, Payable on June 15, 2022 May 03
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia Apr 12
Teleflex Incorporated, Annual General Meeting, Apr 29, 2022 Mar 31
Teleflex Incorporated Announces Board Changes Feb 26 Teleflex Incorporated Declares Quarterly Cash Dividend, Payable March 15, 2022
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures Feb 24
Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures At the American Urological Association 2021 Annual Meeting Sep 15
Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2 System Sep 10
Teleflex Incorporated Announces New Study Provides Insights into the Biocompatibility and Durability of the UroLiftSystem in Improving Benign Prostatic Hyperplasia Symptoms Aug 31
Medline Industries, Inc. completed the acquisition of Certain product lines of global respiratory product portfolio of Teleflex Incorporated. Jun 30 Shareholder Returns T1FX34 BR Medical Equipment BR Market 7D 0% 0.5% 2.9% 1Y n/a 13.0% -6.7%
See full shareholder returns
Return vs Market: Insufficient data to determine how T1FX34 performed against the BR Market .
Price Volatility Is T1FX34's price volatile compared to industry and market? T1FX34 volatility T1FX34 Average Weekly Movement n/a Medical Equipment Industry Average Movement 6.3% Market Average Movement 5.6% 10% most volatile stocks in BR Market 9.9% 10% least volatile stocks in BR Market 3.2%
Stable Share Price: T1FX34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine T1FX34's volatility change over the past year.
About the Company Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Show more Teleflex Incorporated Fundamentals Summary How do Teleflex's earnings and revenue compare to its market cap? T1FX34 fundamental statistics Market cap R$52.12b Earnings (TTM ) R$1.61b Revenue (TTM ) R$16.33b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) T1FX34 income statement (TTM ) Revenue US$3.00b Cost of Revenue US$1.33b Gross Profit US$1.67b Other Expenses US$1.38b Earnings US$296.02m
Last Reported Earnings
Mar 31, 2024
Earnings per share (EPS) 6.28 Gross Margin 55.70% Net Profit Margin 9.86% Debt/Equity Ratio 39.8%
How did T1FX34 perform over the long term?
See historical performance and comparison Dividends
0.7% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/06/24 04:55 End of Day Share Price 2024/03/27 00:00 Earnings 2024/03/31 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Teleflex Incorporated is covered by 35 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Ishan Majumdar Baptista Research Matthew Taylor Barclays Craig Bijou BofA Global Research
Show 32 more analysts 